GARY BUCHER, M.D.
For over 35 years, Dr. Bucher has been a leader in clinical care and research with HIV/ AIDS patients. He has felt the need to be on the forefront of advances and care for PLWH. Dr. Bucher saw the rates of anal cancer increasing in PWH, MSM and other high-risk groups.
Dr. Bucher started referring patients for work up for abnormal anal pap smears (anal cytology) to colorectal surgeons. He soon found out that his patients were not getting the appropriate evaluation with high resolution anoscopy (HRA). His patients were examined with a rectal exam and a standard plain anoscopy. Subsequently, they were told that everything was normal when they could have had anal precancer that was not seen because an HRA was not performed. His patients felt a false sense of security that they were being evaluated properly and that all was normal.
Dr. Bucher quickly found that evaluation and treatment of anal and perianal precancer were nonexistent in Chicago and decided he needed to learn how to perform HRA’s and treat anal precancer. In 2008, Dr. Bucher was so concerned about the trajectory of anal disease in his community, that he started focusing exclusively on providing HRA and HPV related anal disease treatments and opened his Anal Dysplaisa Clinic MidWest (ADC MidWest) in Chicago.
Dr. Bucher’s experience continued to evolve with his clinical practice and research to the point where he was able to participate as the principal investigator in the largest anal cancer prevention study (ANCHOR Study) ever conducted in the USA. Dr. Bucher’s private clinical practice enrolled 580 participants from the Chicagoland region out of the 4,446 total U.S. participants. The ANCHOR Study is an anal cancer prevention clinical trial funded by the National Institutes of Health (NIH) through the National Cancer Institute (NCI) and it’s Office of HIV and AIDS Malignancy (OHAM) and AIDS Malignancy Consortium (AMC).
Dr. Bucher has remained passionate about the the clinical advancements in the treatment of HPV related diseases. In 2020, Dr. Bucher began to develop a mentorship training program to prepare the next generation of providers in anal precancer screening and treatment. The multi-tiered preceptorship program officially launched in 2023 and is primed to fill a much needed gap in the growing need for providers who are proficient in HRA and HSIL treatments. See Provider Preceptorship for more information.
EMILY MILLER, MS WHNP-BC
Emily Miller, APN is an advanced practice nurse at the Anal Dysplasia Clinic MidWest in Chicago. She graduated from University of Illinois-Chicago as a women’s health nurse practitioner in 2016.
She previously worked in reproductive healthcare at Planned Parenthood of Illinois as a nurse practitioner for four years. She was a cardiac nurse at Northwestern Memorial Hospital for five years implementing interventions for heart failure patients prior to her advanced degree. She provides holistic evidence -based care while creating a welcoming space for patients to address their health needs.
Emily is a self-proclaimed foodie and enjoys trying new restaurants all around the city and in her travels. She supports non-kill animal rescues around the city and has three rescued cats and two dogs.